Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor
- 1 August 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 131 (8), 1735-1744
- https://doi.org/10.1038/jid.2011.48
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Basal Cell Nevus SyndromeArchives of Dermatology, 2010
- Hedgehog Signaling in Development and CancerDevelopmental Cell, 2008
- Basal cell carcinomas: attack of the hedgehogNature Reviews Cancer, 2008
- Nonsense-associated altered splicing of the Patched gene fails to suppress carcinogenesis in Gorlin syndromeBritish Journal of Dermatology, 2008
- Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycleGenes & Development, 2004
- Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimusInternational Journal of Pharmaceutics, 2003
- Spectrum of PTCH1 Mutations in French Patients with Gorlin SyndromeJournal of Investigative Dermatology, 2003
- Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonistsJournal of Biology, 2002
- Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndromeAmerican Journal of Medical Genetics, 1997
- Location of gene for Gorlin syndromeThe Lancet, 1992